308 related articles for article (PubMed ID: 29917250)
21. The landscape of m6A regulators in esophageal cancer: molecular characteristics, immuno-oncology features, and clinical relevance.
Li Z; Zheng C; Huang L; Yin X; Wang Z; Liu C; Li B
Ann Transl Med; 2022 Dec; 10(24):1347. PubMed ID: 36660671
[TBL] [Abstract][Full Text] [Related]
22. Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma.
Ibuki Y; Nishiyama Y; Tsutani Y; Emi M; Hamai Y; Okada M; Tahara H
PLoS One; 2020; 15(4):e0231116. PubMed ID: 32251457
[TBL] [Abstract][Full Text] [Related]
23. Trends in Esophageal Cancer Mortality and Stage at Diagnosis by Race and Ethnicity in the United States.
Corona E; Yang L; Esrailian E; Ghassemi KA; Conklin JL; May FP
Cancer Causes Control; 2021 Aug; 32(8):883-894. PubMed ID: 34003396
[TBL] [Abstract][Full Text] [Related]
24.
Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF
Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124
[TBL] [Abstract][Full Text] [Related]
25. The management of localized esophageal squamous cell carcinoma: Western approach.
Zaidi N; Kelly RJ
Chin Clin Oncol; 2017 Oct; 6(5):46. PubMed ID: 29129086
[TBL] [Abstract][Full Text] [Related]
26. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
27. Roles of oncogenes in esophageal squamous cell carcinoma and their therapeutic potentials.
Xiao S; Huang G; Zeng W; Zhou J; Li Y; Fan T; Liu X; Xia J; Zeng X
Clin Transl Oncol; 2023 Mar; 25(3):578-591. PubMed ID: 36315334
[TBL] [Abstract][Full Text] [Related]
28. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.
Sasaki Y; Tamura M; Koyama R; Nakagaki T; Adachi Y; Tokino T
World J Gastroenterol; 2016 Feb; 22(7):2284-93. PubMed ID: 26900290
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA in the pathogenesis and prognosis of esophageal cancer.
Gu J; Wang Y; Wu X
Curr Pharm Des; 2013; 19(7):1292-300. PubMed ID: 23092349
[TBL] [Abstract][Full Text] [Related]
30. ESOMIR: a curated database of biomarker genes and miRNAs associated with esophageal cancer.
Sindhoo A; Sipy S; Khan A; Selvaraj G; Alshammari A; Casida ME; Wei DQ
Database (Oxford); 2023 Oct; 2023():. PubMed ID: 37815872
[TBL] [Abstract][Full Text] [Related]
31. Approach to Localized Squamous Cell Cancer of the Esophagus.
Weidenbaum C; Gibson MK
Curr Treat Options Oncol; 2022 Oct; 23(10):1370-1387. PubMed ID: 36042147
[TBL] [Abstract][Full Text] [Related]
32. Tumoral Expression of CD166 in Human Esophageal Squamous Cell Carcinoma: Implications for Cancer Progression and Prognosis.
Zhang X; Yuan A; Zhao X; Li Z; Cui G
Cancer Biother Radiopharm; 2020 Apr; 35(3):214-222. PubMed ID: 32196367
[TBL] [Abstract][Full Text] [Related]
33. The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies.
Testa U; Castelli G; Pelosi E
Curr Oncol; 2023 Jan; 30(1):610-640. PubMed ID: 36661697
[TBL] [Abstract][Full Text] [Related]
34. Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.
Chen FF; Zhang SR; Peng H; Chen YZ; Cui XB
Mol Med Rep; 2019 Oct; 20(4):3649-3660. PubMed ID: 31485619
[TBL] [Abstract][Full Text] [Related]
35. Survival-associated alternative splicing signatures in esophageal carcinoma.
Mao S; Li Y; Lu Z; Che Y; Sun S; Huang J; Lei Y; Wang X; Liu C; Zheng S; Zang R; Li N; Li J; Sun N; He J
Carcinogenesis; 2019 Mar; 40(1):121-130. PubMed ID: 30304323
[TBL] [Abstract][Full Text] [Related]
36. LncRNA and mRNA integration network reconstruction reveals novel key regulators in esophageal squamous-cell carcinoma.
Alaei S; Sadeghi B; Najafi A; Masoudi-Nejad A
Genomics; 2019 Jan; 111(1):76-89. PubMed ID: 29317304
[TBL] [Abstract][Full Text] [Related]
37. Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.
Ma S; Paiboonrungruan C; Yan T; Williams KP; Major MB; Chen XL
Ann N Y Acad Sci; 2018 Dec; 1434(1):164-172. PubMed ID: 29752726
[TBL] [Abstract][Full Text] [Related]
38. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.
Sudo K; Kato K; Matsuzaki J; Boku N; Abe S; Saito Y; Daiko H; Takizawa S; Aoki Y; Sakamoto H; Niida S; Takeshita F; Fukuda T; Ochiya T
JAMA Netw Open; 2019 May; 2(5):e194573. PubMed ID: 31125107
[TBL] [Abstract][Full Text] [Related]
39. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
40. Current advances in esophageal cancer proteomics.
Uemura N; Kondo T
Biochim Biophys Acta; 2015 Jun; 1854(6):687-95. PubMed ID: 25233958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
